Global Gaucher Disease (GD) Drugs Market Research Report 2023

Report ID: 2005716 | Published Date: Jan 2025 | No. of Page: 81 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gaucher Disease (GD) Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Enzyme Replacement Therapy
        1.2.3 Substrate Reduction Therapy
    1.3 Market by Application
        1.3.1 Global Gaucher Disease (GD) Drugs Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Non-neuronopathic Gaucher Disease
        1.3.3 Neuronopathic Gaucher Disease
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gaucher Disease (GD) Drugs Market Perspective (2017-2028)
    2.2 Gaucher Disease (GD) Drugs Growth Trends by Region
        2.2.1 Gaucher Disease (GD) Drugs Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gaucher Disease (GD) Drugs Historic Market Size by Region (2017-2022)
        2.2.3 Gaucher Disease (GD) Drugs Forecasted Market Size by Region (2023-2028)
    2.3 Gaucher Disease (GD) Drugs Market Dynamics
        2.3.1 Gaucher Disease (GD) Drugs Industry Trends
        2.3.2 Gaucher Disease (GD) Drugs Market Drivers
        2.3.3 Gaucher Disease (GD) Drugs Market Challenges
        2.3.4 Gaucher Disease (GD) Drugs Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gaucher Disease (GD) Drugs Players by Revenue
        3.1.1 Global Top Gaucher Disease (GD) Drugs Players by Revenue (2017-2022)
        3.1.2 Global Gaucher Disease (GD) Drugs Revenue Market Share by Players (2017-2022)
    3.2 Global Gaucher Disease (GD) Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gaucher Disease (GD) Drugs Revenue
    3.4 Global Gaucher Disease (GD) Drugs Market Concentration Ratio
        3.4.1 Global Gaucher Disease (GD) Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gaucher Disease (GD) Drugs Revenue in 2021
    3.5 Gaucher Disease (GD) Drugs Key Players Head office and Area Served
    3.6 Key Players Gaucher Disease (GD) Drugs Product Solution and Service
    3.7 Date of Enter into Gaucher Disease (GD) Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gaucher Disease (GD) Drugs Breakdown Data by Type
    4.1 Global Gaucher Disease (GD) Drugs Historic Market Size by Type (2017-2022)
    4.2 Global Gaucher Disease (GD) Drugs Forecasted Market Size by Type (2023-2028)
5 Gaucher Disease (GD) Drugs Breakdown Data by Application
    5.1 Global Gaucher Disease (GD) Drugs Historic Market Size by Application (2017-2022)
    5.2 Global Gaucher Disease (GD) Drugs Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gaucher Disease (GD) Drugs Market Size (2017-2028)
    6.2 North America Gaucher Disease (GD) Drugs Market Size by Country (2017-2022)
    6.3 North America Gaucher Disease (GD) Drugs Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gaucher Disease (GD) Drugs Market Size (2017-2028)
    7.2 Europe Gaucher Disease (GD) Drugs Market Size by Country (2017-2022)
    7.3 Europe Gaucher Disease (GD) Drugs Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gaucher Disease (GD) Drugs Market Size (2017-2028)
    8.2 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gaucher Disease (GD) Drugs Market Size (2017-2028)
    9.2 Latin America Gaucher Disease (GD) Drugs Market Size by Country (2017-2022)
    9.3 Latin America Gaucher Disease (GD) Drugs Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gaucher Disease (GD) Drugs Market Size (2017-2028)
    10.2 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Detail
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Gaucher Disease (GD) Drugs Introduction
        11.1.4 Sanofi Revenue in Gaucher Disease (GD) Drugs Business (2017-2022)
        11.1.5 Sanofi Recent Development
    11.2 Shire
        11.2.1 Shire Company Detail
        11.2.2 Shire Business Overview
        11.2.3 Shire Gaucher Disease (GD) Drugs Introduction
        11.2.4 Shire Revenue in Gaucher Disease (GD) Drugs Business (2017-2022)
        11.2.5 Shire Recent Development
    11.3 Actelion Pharma
        11.3.1 Actelion Pharma Company Detail
        11.3.2 Actelion Pharma Business Overview
        11.3.3 Actelion Pharma Gaucher Disease (GD) Drugs Introduction
        11.3.4 Actelion Pharma Revenue in Gaucher Disease (GD) Drugs Business (2017-2022)
        11.3.5 Actelion Pharma Recent Development
    11.4 Pfizer (Protalix)
        11.4.1 Pfizer (Protalix) Company Detail
        11.4.2 Pfizer (Protalix) Business Overview
        11.4.3 Pfizer (Protalix) Gaucher Disease (GD) Drugs Introduction
        11.4.4 Pfizer (Protalix) Revenue in Gaucher Disease (GD) Drugs Business (2017-2022)
        11.4.5 Pfizer (Protalix) Recent Development
    11.5 ISU ABXIS
        11.5.1 ISU ABXIS Company Detail
        11.5.2 ISU ABXIS Business Overview
        11.5.3 ISU ABXIS Gaucher Disease (GD) Drugs Introduction
        11.5.4 ISU ABXIS Revenue in Gaucher Disease (GD) Drugs Business (2017-2022)
        11.5.5 ISU ABXIS Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Gaucher Disease (GD) Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Enzyme Replacement Therapy
    Table 3. Key Players of Substrate Reduction Therapy
    Table 4. Global Gaucher Disease (GD) Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 5. Global Gaucher Disease (GD) Drugs Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gaucher Disease (GD) Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 7. Global Gaucher Disease (GD) Drugs Market Share by Region (2017-2022)
    Table 8. Global Gaucher Disease (GD) Drugs Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 9. Global Gaucher Disease (GD) Drugs Market Share by Region (2023-2028)
    Table 10. Gaucher Disease (GD) Drugs Market Trends
    Table 11. Gaucher Disease (GD) Drugs Market Drivers
    Table 12. Gaucher Disease (GD) Drugs Market Challenges
    Table 13. Gaucher Disease (GD) Drugs Market Restraints
    Table 14. Global Gaucher Disease (GD) Drugs Revenue by Players (2017-2022) & (US$ Million)
    Table 15. Global Gaucher Disease (GD) Drugs Market Share by Players (2017-2022)
    Table 16. Global Top Gaucher Disease (GD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher Disease (GD) Drugs as of 2021)
    Table 17. Ranking of Global Top Gaucher Disease (GD) Drugs Companies by Revenue (US$ Million) in 2021
    Table 18. Global 5 Largest Players Market Share by Gaucher Disease (GD) Drugs Revenue (CR5 and HHI) & (2017-2022)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Gaucher Disease (GD) Drugs Product Solution and Service
    Table 21. Date of Enter into Gaucher Disease (GD) Drugs Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Gaucher Disease (GD) Drugs Market Size by Type (2017-2022) & (US$ Million)
    Table 24. Global Gaucher Disease (GD) Drugs Revenue Market Share by Type (2017-2022)
    Table 25. Global Gaucher Disease (GD) Drugs Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 26. Global Gaucher Disease (GD) Drugs Revenue Market Share by Type (2023-2028)
    Table 27. Global Gaucher Disease (GD) Drugs Market Size by Application (2017-2022) & (US$ Million)
    Table 28. Global Gaucher Disease (GD) Drugs Revenue Market Share by Application (2017-2022)
    Table 29. Global Gaucher Disease (GD) Drugs Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 30. Global Gaucher Disease (GD) Drugs Revenue Market Share by Application (2023-2028)
    Table 31. North America Gaucher Disease (GD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 32. North America Gaucher Disease (GD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 33. Europe Gaucher Disease (GD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 34. Europe Gaucher Disease (GD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 35. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region (2017-2022) & (US$ Million)
    Table 36. Asia-Pacific Gaucher Disease (GD) Drugs Market Size by Region (2023-2028) & (US$ Million)
    Table 37. Latin America Gaucher Disease (GD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Latin America Gaucher Disease (GD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2017-2022) & (US$ Million)
    Table 40. Middle East & Africa Gaucher Disease (GD) Drugs Market Size by Country (2023-2028) & (US$ Million)
    Table 41. Sanofi Company Detail
    Table 42. Sanofi Business Overview
    Table 43. Sanofi Gaucher Disease (GD) Drugs Product
    Table 44. Sanofi Revenue in Gaucher Disease (GD) Drugs Business (2017-2022) & (US$ Million)
    Table 45. Sanofi Recent Development
    Table 46. Shire Company Detail
    Table 47. Shire Business Overview
    Table 48. Shire Gaucher Disease (GD) Drugs Product
    Table 49. Shire Revenue in Gaucher Disease (GD) Drugs Business (2017-2022) & (US$ Million)
    Table 50. Shire Recent Development
    Table 51. Actelion Pharma Company Detail
    Table 52. Actelion Pharma Business Overview
    Table 53. Actelion Pharma Gaucher Disease (GD) Drugs Product
    Table 54. Actelion Pharma Revenue in Gaucher Disease (GD) Drugs Business (2017-2022) & (US$ Million)
    Table 55. Actelion Pharma Recent Development
    Table 56. Pfizer (Protalix) Company Detail
    Table 57. Pfizer (Protalix) Business Overview
    Table 58. Pfizer (Protalix) Gaucher Disease (GD) Drugs Product
    Table 59. Pfizer (Protalix) Revenue in Gaucher Disease (GD) Drugs Business (2017-2022) & (US$ Million)
    Table 60. Pfizer (Protalix) Recent Development
    Table 61. ISU ABXIS Company Detail
    Table 62. ISU ABXIS Business Overview
    Table 63. ISU ABXIS Gaucher Disease (GD) Drugs Product
    Table 64. ISU ABXIS Revenue in Gaucher Disease (GD) Drugs Business (2017-2022) & (US$ Million)
    Table 65. ISU ABXIS Recent Development
    Table 66. Research Programs/Design for This Report
    Table 67. Key Data Information from Secondary Sources
    Table 68. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gaucher Disease (GD) Drugs Market Share by Type: 2021 VS 2028
    Figure 2. Enzyme Replacement Therapy Features
    Figure 3. Substrate Reduction Therapy Features
    Figure 4. Global Gaucher Disease (GD) Drugs Market Share by Application in 2021 & 2028
    Figure 5. Non-neuronopathic Gaucher Disease Case Studies
    Figure 6. Neuronopathic Gaucher Disease Case Studies
    Figure 7. Gaucher Disease (GD) Drugs Report Years Considered
    Figure 8. Global Gaucher Disease (GD) Drugs Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 9. Global Gaucher Disease (GD) Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 10. Global Gaucher Disease (GD) Drugs Market Share by Region: 2021 VS 2028
    Figure 11. Global Gaucher Disease (GD) Drugs Market Share by Players in 2021
    Figure 12. Global Top Gaucher Disease (GD) Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gaucher Disease (GD) Drugs as of 2021)
    Figure 13. The Top 10 and 5 Players Market Share by Gaucher Disease (GD) Drugs Revenue in 2021
    Figure 14. North America Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 15. North America Gaucher Disease (GD) Drugs Market Share by Country (2017-2028)
    Figure 16. United States Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. Canada Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 18. Europe Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Europe Gaucher Disease (GD) Drugs Market Share by Country (2017-2028)
    Figure 20. Germany Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. France Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. U.K. Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Italy Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. Russia Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Nordic Countries Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Asia-Pacific Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Asia-Pacific Gaucher Disease (GD) Drugs Market Share by Region (2017-2028)
    Figure 28. China Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Japan Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. South Korea Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Southeast Asia Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. India Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Australia Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. Latin America Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Latin America Gaucher Disease (GD) Drugs Market Share by Country (2017-2028)
    Figure 36. Mexico Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Brazil Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Middle East & Africa Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Middle East & Africa Gaucher Disease (GD) Drugs Market Share by Country (2017-2028)
    Figure 40. Turkey Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Saudi Arabia Gaucher Disease (GD) Drugs Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Sanofi Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2017-2022)
    Figure 43. Shire Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2017-2022)
    Figure 44. Actelion Pharma Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2017-2022)
    Figure 45. Pfizer (Protalix) Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2017-2022)
    Figure 46. ISU ABXIS Revenue Growth Rate in Gaucher Disease (GD) Drugs Business (2017-2022)
    Figure 47. Bottom-up and Top-down Approaches for This Report
    Figure 48. Data Triangulation
    Figure 49. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Shire
Actelion Pharma
Pfizer (Protalix)
ISU ABXIS
Frequently Asked Questions
Gaucher Disease (GD) Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gaucher Disease (GD) Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gaucher Disease (GD) Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports